SARS-CoV-2 Omicron variant

European Commission Approves Novavax's Adapted COVID-19 Vaccine for Winter Season

The European Commission has granted approval for the Nuvaxovid XBB.1.5-adapted COVID-19 vaccine, a groundbreaking step in the fight against the ever-evolving pandemic. Developed by Novavax, this marks the first protein-based vaccine tailored to address the unique challenges posed by the autumn-winter season.

The ninth corona wave is in sight

Officially, it was announced today that the omicron sub-variant, "eris", was also registered in Serbia.
In the past week in Serbia, 686 people out of 4,705 tested citizens fell ill with the corona virus. That's why doctors appeal to citizens that if they have symptoms of a respiratory infection, they should not go to collectives, but rather "lying down" the infection.

New COVID variant not detected in Türkiye, minister says

Health Minister Fahrettin Koca has announced that the country has not detected the presence of the new variant of COVID-19, EG.5, within its borders.

"Do not worry about these variants. There is no such thing as a transition to the periods that we have closed," Koca declared in a press address held in the Central Anatolian province of Kırşehir on Aug. 23.

Eris spreading, but experts say symptoms are mild

Health authorities worldwide are concerned about the rapid spread of the new EG.5.1 subvariant (Eris) of the Omicron strain of SARS-CoV-2. In particular, there is concern about the coming fall. Due to summer holidays and closed schools the spread of Eris may be slow, but come September, when people start spending more time indoors, it may dominate.

Pages